We have collected the most relevant information on Claudio Zamagni Bologna. Open the URLs, which are collected below, and you will find all the info you are interested in.
Claudio Zamagni — University of Bologna — Home Page
https://www.unibo.it/sitoweb/claudio.zamagni/en
Claudio Zamagni Professore a contratto a titolo gratuito per attività professionalizzanti nelle scuole di specializzazione di area sanitaria, ex D.I. 68/2015 Department of Experimental, Diagnostic and Specialty Medicine - DIMES
Prof. Claudio Zamagni – Oncologo
https://claudiozamagni.it/
Il Prof. Claudio Zamagni è esperto in Oncologia. Si occupa principalmente dei tumori ginecologici e della mammella ed ha esperienza nella diagnosi e nel trattamento di tutte le principali neoplasie non ematologiche. Attualmente è Dirigente della S.S.D. di Oncologia Medica Addarii presso l’Ospedale S. Orsola-Malpighi di Bologna.
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer ...
https://clinicaltrials.gov/ct2/show/NCT02125513
Claudio Zamagni MD, MD Medical Oncologist, IRCCS Azienda Ospedaliero-Universitaria di Bologna: ClinicalTrials.gov Identifier: NCT02125513 Other Study ID Numbers: GOGER-01 2013-002520-17 ( EudraCT Number ) First Posted: April 29, 2014 Key Record Dates: Last Update Posted: February 23, 2021 Last Verified:
Follow-up of Early Breast Cancer by ... - ClinicalTrials.gov
https://clinicaltrials.gov/ct2/show/NCT02261389
Claudio Zamagni MD, MD Medical Oncologist, IRCCS Azienda Ospedaliero-Universitaria di Bologna: ClinicalTrials.gov Identifier: NCT02261389 Other Study ID Numbers: KRONOS PONS-S Italy ( Other Identifier: S.Orsola-Malpighi Hospital ) First Posted: October 10, 2014 Key Record Dates: Last Update Posted: July 15, 2020
Food Supplements Based on Nettle and ... - …
https://www.clinicaltrials.gov/ct2/show/NCT04474951
Claudio Zamagni MD, MD Medical Oncologist, IRCCS Azienda Ospedaliero-Universitaria di Bologna: ClinicalTrials.gov Identifier: NCT04474951 Other Study ID Numbers: GALENO 1 : First Posted: July 17, 2020 Key Record Dates: Last Update Posted: July 17, 2020 Last Verified: July 2020
Evaluation of the Predictive Value of Blood Levels of ...
https://www.clinicaltrials.gov/ct2/show/NCT04770376
Claudio Zamagni MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief Summary: This is a monocentric prospective observational pilot study of translational research in women with advanced ovarian epithelial cancer.
La chemioterapia in - Project & Communication
https://ecm.project-communication.it/upload/lezioni/101082/02_chemioterapia.pdf
Claudio Zamagni Bologna 28 novembre 2014 Rate of Spontaneous Abortion Following Cancer Chemotherapy Use During Pregnancy, All Agents First tr. 13%* (42/327) Second/Third tr. 2%** (20/836) *Spontaneous fetal loss at < 22 weeks of gestation ; the result is similar to that observed in healthy women
12. New Perspectives on Eusebius’ Questions and Answers on ...
https://archive.chs.harvard.edu/CHS/article/display/5878.12-new-perspectives-on-eusebius’-questions-and-answers-on-the-gospels-the-manuscripts-claudio-zamagni
Claudio Zamagni Eusebius wrote a large number of works; each of them would probably have been enough to make him one of the major Christian authors of his time. Among his less famous works stand the Questions and Answers on the Gospels, [ 2 ] an innovation in Christian literature—a sort of compendium of exegesis concerning different ...
Safety profile of subcutaneous trastuzumab for the ...
https://pubmed.ncbi.nlm.nih.gov/30396014/
Milvia Zambetti 1 , Filippo Montemurro 2 , Paolo Morandi 3 , Claudio Zamagni 4 , Alba A Brandes 5 , Giancarlo Bisagni 6 , Katia Cagossi 7 , Carmelo Bengala 8 , Stefania Gori 9 , Claudio Iannacone 10 , Alessia Stell 11 , Luca Gianni 12
What Is New on Ovarian Carcinoma: Integrated …
https://pubmed.ncbi.nlm.nih.gov/33919741/
Affiliations 1 Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.; 2 Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna/Azienda USL di Bologna, 40138 Bologna, Italy.; 3 Centro di Studio e Ricerca delle Neoplasie Ginecologiche, Alma Mater …
Now you know Claudio Zamagni Bologna
Now that you know Claudio Zamagni Bologna, we suggest that you familiarize yourself with information on similar questions.
